Company profileNutraceutical & supplements#155 of 1,318 in Pakistan✓ No DRAP alerts

MSG Nutraceuticals, Islamabad

Nutraceutical & supplement manufacturer · 111 registered products

Ranked #7 of 19 companies in Gonadotropins And Other Ovulation Stimulants

111 registered products 8 distinct molecules 0 DRAP alerts
111 of this company's registrations sit in the DRAP category “Nutritional Supplement / Multivitamin”, which is registered as a category rather than by molecule — so a low molecule count reflects how supplements are registered, not a small portfolio. Nutraceutical manufacturers advertise direct to consumers and are among the largest marketing spenders in the Pakistani market.

Company overview

111
registered products
8
distinct molecules
2
therapeutic classes
0
DRAP alerts

MSG Nutraceuticals, Islamabad is a nutraceutical and dietary-supplement manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 111 product registrations. It is the 155th largest registrant in Pakistan by product count, and ranks 7th of 19 in Gonadotropins And Other Ovulation Stimulants. Its portfolio is concentrated in Gonadotropins And Other Ovulation Stimulants and Blood Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by MSG

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Gonadotropins And Other Ovulation Stimulants 1

Top molecules by brand count

Nutritional Supplement / Multivitamin111 brands
Famotidine1 brand
Chorionic Gonadotrophin (Human Chorionic Gonadotrophin1 brand
Hcg)1 brand

Therapeutic classes

Gonadotropins And Other Ovulation Stimulants · 1Blood Conditions · 1

Conditions treated

Haematopoiesis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 2,978 – Rs 2,978
Servaid1 products · Rs 1,008.3 – Rs 1,008.3
Median across source: Rs 2,978

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

ALLMED LABORATORIES3 shared molecules
SEARLE PAKISTAN (PVT.) LTD.3 shared molecules
GALAXY PHARMA (PVT) LTD.3 shared molecules
Martin Dow Marker Limited2 shared molecules
OBS Pharma (Pvt) Ltd2 shared molecules
LEO/ZAMZAM2 shared molecules
IRZA PHARMA (PVT) LTD.2 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

ALLMED LABORATORIES holds 62 molecules not in this portfolio
AlbuterolArtemetherArtesunateAscorbic AcidAzithromycinCalcium
SEARLE PAKISTAN (PVT.) LTD. holds 237 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline
Pfizer Laboratories (Pvt) Ltd. holds 132 molecules not in this portfolio
AlprazolamAluminium HydroxideAluminium Hydroxide And OxideAmlodipineAmodiaquineAmodiaquine Base

Get the full profile for MSG

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.